IMVT — IMMUNOVANT INC

Ownership history in Boxer Capital, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Boxer Capital, LLC reported a position in IMMUNOVANT INC (IMVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.1% (2023 Q4)
Avg. % of fund
1.17%
First filed
2021 Q1
Last filed
2024 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q4 UNCHANGED 825,000 — 0% 1.15% $23.5M $24.77
2024 Q3 UNCHANGED 825,000 — 0% 1.15% $23.5M $28.51
2024 Q2 UNCHANGED 825,000 — 0% 1.15% $21.8M $26.40
2024 Q1 REDUCED 825,000 -175,000 -17.5% 1.32% $26.7M $32.31
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IMVT price (monthly, adj. close)

Other funds also holding IMVT

As of 2025 Q4 — sorted by position size

Alpine Global Management, LLC 3Y 7Y 11.36% GREAT POINT PARTNERS LLC 3Y 7Y 6.18% Deep Track Capital, LP 3Y 5.22% ADAR1 Capital Management, LLC 4.57% SUPERSTRING CAPITAL MANAGEMENT LP 3.93% STEMPOINT CAPITAL LP 2.81% Logos Global Management LP 3Y 2.11% Exome Asset Management LLC 1.93% ARMISTICE CAPITAL, LLC 3Y 7Y 1.74% Two Seas Capital LP 3Y 1.5%
← Back to Boxer Capital, LLC Holdings